Elevated Lp(a) in People at Risk of or with Established Heart Disease or Stroke
Upcoming
-
Adelaide SA
Effect of Muvalaplin on the reduction of major adverse cardiovascular events in adults with elevated Lipoprotein(a), who have had a prior atherosclerotic cardiovascular event, or are at risk for a first atherosclerotic cardiovascular event.
- Age > 18 years
- Lp(a) blood test taken at screening visit
- Oral tablet taken daily
Payment / Remuneration
- Reimbursed for travel
Information for Practitioners
- Lp(a) blood test taken at screening visit